General Information
Revision date
2026-04-23
Product name
Tissue Lysis Buffer
1.2.1 Relevant identified uses
Laboratory chemicals, Refer to product literature for further details
Emergency telephone
+49(0)621-759-2203, +49(0)6131-19240
Icons in SDS
Company Information
company name
Roche Diagnostics Deutschland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.dia-sds@roche.com
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Additional information
EUH210 Safety data sheet available on request.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Not a hazardous substance or mixture. 2.2 Label elements Labelling (REGULATION (EC) No 1272/2008) No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required. Additional Labelling EUH210 Safety data sheet available on request. 2.3 Other hazards This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Ecological information: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Toxicological information: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. SECTION 3: Composition/information on ingredients 3.2 Mixtures Components Chemical name CAS-No. Classification Concentration EC-No. (% w/w) Index-No. Registration number Ethylenediaminetetraacetic acid 6381-92-6 Acute Tox. 4; H332 >= 1,0 - < 10,0 disodium salt dihydrate STOT RE 2; H373 01-2119486775-20 (Respiratory system) For explanation of abbreviations see section 16. SECTION 4: First aid measures 4.1 Description of first aid measures General advice : Do not leave the victim unattended. If inhaled : If unconscious, place in recovery position and seek medical advice. If symptoms persist, call a physician. In case of skin contact : Wash off with soap and water. In case of eye contact : Remove contact lenses. Protect unharmed eye. If eye irritation persists, consult a specialist. If swallowed : Keep respiratory tract clear. Do not give milk or alcoholic beverages. Never give anything by mouth to an unconscious person. If symptoms persist, call a physician. 4.2 Most important symptoms and effects, both acute and delayed None known. 4.3 Indication of any immediate medical attention and special treatment needed Treatment : Treat symptomatically.
